Tiantan Biotech: Chengdu Rongsheng receives notification of compliance with drug GMP inspection.

Tiantan Bio announced that its subsidiary Chengdu Rongsheng Pharmaceutical Co., Ltd. has received the "Notice of Compliance Inspection for Drug GMP" issued by the Sichuan Provincial Drug Administration. The certificate number is Chuanxu 2025169, the inspection time is from June 16 to June 19, 2025, and the inspection conclusion is that it meets the requirements of the "Drug Production Quality Management Specification" and relevant appendices. Receiving this notice means that the production workshop for recombined products of Chengdu Rongsheng meets the national GMP requirements. After obtaining the registration certificate for "Recombinant Human Coagulation Factor VIIa for Injection" and final production permit, the production of this product can be realized.